Clinical Trial Update: The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy [EARLY_Phase 1]

View source ↗

Summary

An EARLY_PHASE1 clinical trial is evaluating everolimus as an adjunctive treatment for focal refractory epilepsy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Epilepsy, Drug Resistant | EARLY_Phase 1 | Status: RECRUITING